Reaction

Pulmonary Infarction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,354 reports · 35 co-occurring drugs

As of the last recalculation, Pulmonary Infarction appears in 2,354 FAERS reports alongside 35 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL AND ETHINYL ESTRADIOL (PRR 157.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Etonogestrel And Ethinyl Estradiol338157.2159.6
Drospirenone And Ethinyl Estradiol505128.4129.8
Ibuprofen And Diphenhydramine Citrate4115.815.9
Testosterone Cypionate1514.915.0
Baricitinib1312.012.0
Azithromycin Dihydrate7010.810.9
Azithromycin4510.110.1
Leucovorin Calcium219.89.8
Azithromycin Monohydrate459.79.7
Heparin Sodium159.79.7
Ascorbic Acid249.29.2
Testosterone249.29.2
Dalteparin Sodium108.48.4
Rizatriptan Benzoate87.07.0
Fondaparinux Sodium66.66.6
Pegaspargase96.56.5
Busulfan116.26.2
Raloxifene Hydrochloride106.16.1
Remdesivir96.06.0
Tranexamic Acid66.06.0
Loratadine And Pseudoephedrine Sulfate55.65.6
Fluorouracil Cream, 0.5%445.25.2
Fluorouracil445.15.1
Vincristine Sulfate154.54.6
Panitumumab84.54.5
Oxycodone Hydrochloride And Acetaminophen464.24.2
Irinotecan Hydrochloride64.14.1
Temozolomide93.83.8
Paricalcitol63.83.8
Axitinib83.63.6
Hydrocodone Bitartrate And Acetaminophen223.53.5
Eltrombopag Olamine83.13.1
Cabozantinib132.42.4
Voxelotor41.61.6
Etonogestrel81.51.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.